A Loop-Mediated Isothermal Amplification (LAMP) kit for rapid detection of multiple bacteria involved in neonatal sepsis. LAMP is a simple rapid diagnostic tool for early detection and identification of microbial pathogens. As a unique single tube method, it can amplify DNA efficiently (up to 109 target DNA copies) within an hour under isothermal conditions (60-65°C) without a need for complex instruments or skilled expertise. 

This kit is designed as an affordable point of care device for the resource limited settings. It offers a faster, portable, and cost-effective alternative. We have developed this kit for specific detection of eight bacterial pathogens from blood. This will help in the quick identification of bacteria within 45-60 minutes by helping the clinicians to choose timely treatment with the right antibiotics in preventing neonatal deaths. Also, it can help reduce the overuse of broad-spectrum antibiotics and contribute to combating antimicrobial resistance (AMR).

A novel in situ eye gel developed by ProCyto Labs in collaboration with LV Prasad Eye Institute, with funding support from BIRAC under the BIG program. This drug-free, preservative-free formulation transforms into a gel upon contact with tear fluid, forming a protective barrier over the ocular surface to help prevent allergen interaction. The formulation has been successfully evaluated in preclinical studies demonstrating strong safety and compatibility with ocular tissues. The formulation is classified under the medical device category “C”as per the Central Drugs Standard Control Organization.

At the intersection of biotechnology and artificial intelligence, we are pioneering a shift in how neurodevelopmental conditions are identified. Our innovation transforms the subtle “texture” of a child’s voice into a powerful, objective diagnostic biomarker for Autism Spectrum Disorder (ASD).

For decades, vocal research in autism focused on “Prosody”, the melody, pitch, and rhythm of speech. While valuable, these features are often influenced by environment and culture.

Our innovation looks deeper. Using high-dimensional spectral analysis, our AI identifies Acoustic Texture, sub-perceptual signatures in the vocal tract that are invisible to the human ear. By focusing on these biological markers, we provide a level of diagnostic precision that transcends traditional behavioral observation.

Current diagnostic paths for autism can take years, missing the critical windows of early neuroplasticity. Our mission is to democratize this process.

By integrating our AI-enabled sensor into primary pediatric care and rural health outposts, we are building a world where a child’s location or background does not dictate their access to early intervention. We are not just building an algorithm; we are building a roadmap for the future of neurodevelopmental monitoring.

Early-stage development supported by ICMR in collaboration with ICMR-RMRC